At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 45 enrolled
Drug / intervention
10 mg Bupivacaine +1 moredrug
Likely dose
10 mg Bupivacainefrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparing Low-dose Bupivacaine With Epidural Volume Extension to Standard Bupivacaine Dosing for Short Obstetric Procedures: A Prospective, Randomized Study
In Brief
A Phase 3 clinical trial evaluating 10 mg Bupivacaine and 5 mg Bupivacaine for Spinal Anesthesia and Epidural; Anesthesia. Completed, enrolled 45 participants across 1 site.
Detailed Summary
In this study the investigator will address the efficacy of using low dose bupivacaine spinal anesthesia (SA) in combination with epidural volume extension (EVE) for patients undergoing short obstetric procedures.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSpinal Anesthesia, Epidural; Anesthesia
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
2017201820192020202120222023202420252026
Enrollment StartJun 2016
First PostedApr 2017
Primary CompletionDec 2017
Study CompletionSep 2018
TodayJul 2026
First PostedApr 12, 2017
Enrollment StartJun 27, 2016
Primary CompletionDec 1, 2017
Study CompletionSep 30, 2018
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 9.2 years ago
Interventions
10 mg Bupivacainedrug
10 mg of preservative-free isobaric bupivacaine with 12.5mcg of fentanyl injected to the epidural space
5 mg Bupivacainedrug
5 mg of preservative-free isobaric bupivacaine with 12.5mcg of fentanyl in combination with 10 mL of sterile saline injected into the epidural space.